FTC

Pharma

In less than 3 months, AbbVie closes $10.1B buyout of ImmunoGen

AbbVie has closed its $10.1B buyout of ImmunoGen. And the good news from an industry perspective is that deal took less than three months to complete.

Kevin Dunleavy Feb 12, 2024 10:55am

M&A is on the rise. Analysts see more of the same in 2024

Dec 22, 2023 8:46am

Pfizer says $43B buyout of Seagen will be complete this week

Dec 12, 2023 10:56am

FTC takes aim at 'sham' biopharma patents

Sep 14, 2023 3:55pm

FTC mulls settlement as industry rallies behind Amgen, Horizon

Aug 28, 2023 10:40am

Amgen fights FTC's request for injunction against Horizon buyout

Aug 24, 2023 11:12am